Post-pandemic trends in <i>Streptococcus pneumoniae</i> serotype epidemiology and antibiotic susceptibility in adults with invasive and non-invasive pneumococcal disease in the USA (2022–2023)
Based on surveillance data from the SENTRY Antimicrobial Surveillance Program, PCV21 serotypes were associated with 82% of IPD and non-IPD cases in adults although PCV21-unique serotypes had lower rates of susceptibility to commonly used antibiotics. Continued surveillance is crucial to track serotype and resistance trends.
Authors
- Kristen A. Feemster (ORCID: https://orcid.org/0000-0003-0822-5688)
- Kenneth Klinker (ORCID: https://orcid.org/0000-0002-0318-7099)
- Rodrigo E. Mendes (ORCID: https://orcid.org/0000-0002-8648-1137)
- Jason M. Cota
- Mekki Bensaci
- Karri A. Bauer
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- JMI Laboratories (US)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1093/jac/dkaf414
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00